BARCLAYS PLC - BIOXCEL THERAPEUTICS INC ownership

BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 98 filers reported holding BIOXCEL THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of BIOXCEL THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$18
-97.3%
7,656
-92.4%
0.00%
Q2 2023$671
-35.8%
100,720
+79.8%
0.00%
Q1 2023$1,045
+841.4%
56,023
+990.8%
0.00%
Q4 2022$111
-98.9%
5,136
+533.3%
0.00%
Q3 2022$10,000
-68.8%
811
-66.7%
0.00%
Q2 2022$32,000
-47.5%
2,437
-15.6%
0.00%
Q1 2022$61,000
-92.8%
2,889
-93.1%
0.00%
Q4 2021$852,000
+171.3%
41,858
+304.8%
0.00%
Q3 2021$314,000
+82.6%
10,341
+74.9%
0.00%
Q2 2021$172,000
+681.8%
5,912
+1131.7%
0.00%
Q4 2020$22,000
-98.2%
480
-98.3%
0.00%
-100.0%
Q3 2020$1,235,000
+3759.4%
28,487
+4647.8%
0.00%
Q2 2020$32,000
-68.3%
600
-91.4%
0.00%
Q4 2019$101,000
+381.0%
6,940
+133.5%
0.00%
Q3 2019$21,000
-51.2%
2,972
-23.5%
0.00%
Q2 2019$43,000
-99.3%
3,886
-99.4%
0.00%
-100.0%
Q1 2018$6,331,000618,2490.01%
Other shareholders
BIOXCEL THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Logos Global Management LP 430,000$19,866,0001.70%
APIS CAPITAL ADVISORS, LLC 20,000$924,0000.89%
Avidity Partners Management LP 547,000$25,271,0000.82%
Knoll Capital Management, LLC 20,000$924,0000.63%
Artemis Investment Management LLP 1,013,448$46,839,0000.49%
AlphaCentric Advisors LLC 25,000$1,155,0000.48%
First Light Asset Management, LLC 94,202$4,352,0000.32%
Ikarian Capital, LLC 150,000$6,930,0000.31%
Longitude (Cayman) Ltd. 8,000$370,0000.18%
AllSquare Wealth Management LLC 5,490$254,0000.17%
View complete list of BIOXCEL THERAPEUTICS INC shareholders